What we can do is lay out exactly what the clinical evidence says, explain how the drugs differ mechanically, and help you understand who each one tends to suit best
The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8
In fact, most access to sites have you pay a flat fee of around $99
doi: 10.1136/THORAX.55.SUPPL_2.S51 73 GhoshSJanochaAJAronicaMASwaidaniSComhairSAAXuWet al
This is the most direct evidence of shelf life performance
Darker coloring indicates oxidation, do not use